ENLV icon

Enlivex Therapeutics

6 hedge funds and large institutions have $4.49M invested in Enlivex Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
4
Increased
2
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$2.09M +$2.09M +445,673 New
CH
2
CVI Holdings
Delaware
$1.81M +$1.81M +385,621 New
Renaissance Technologies
3
Renaissance Technologies
New York
$445K +$265K +56,600 +147%
Morgan Stanley
4
Morgan Stanley
New York
$132K +$132K +28,147 +1,407,350%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$22K +$22K +4,540 New
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$3K +$3K +621 New
AIM
7
ARK Investment Management
Florida
-$323K -38,536 Closed
UBS Group
8
UBS Group
Switzerland
-$24K -2,873 Closed
Deutsche Bank
9
Deutsche Bank
Germany
-$3K -418 Closed